The Broad Institute Joins the Illumina, Inc. Genome Network
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that the Broad Institute has joined the Illumina Genome Network (IGN) to offer its proprietary sample preparation processes for whole human genome sequencing. The Broad’s pioneering approach enables high-quality sequencing of challenging low input DNA (<500 ng) and formalin-fixed, paraffin-embedded (FFPE) samples.